Globus Medical Inc
NYSE:GMED

Watchlist Manager
Globus Medical Inc Logo
Globus Medical Inc
NYSE:GMED
Watchlist
Price: 84.53 USD 0.05% Market Closed
Market Cap: 11.4B USD
Have any thoughts about
Globus Medical Inc?
Write Note

Globus Medical Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Globus Medical Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Globus Medical Inc
NYSE:GMED
Other Long-Term Assets
$120.4m
CAGR 3-Years
48%
CAGR 5-Years
41%
CAGR 10-Years
61%
Becton Dickinson and Co
NYSE:BDX
Other Long-Term Assets
$2.6B
CAGR 3-Years
10%
CAGR 5-Years
19%
CAGR 10-Years
18%
Boston Scientific Corp
NYSE:BSX
Other Long-Term Assets
$4.5B
CAGR 3-Years
-1%
CAGR 5-Years
19%
CAGR 10-Years
28%
Stryker Corp
NYSE:SYK
Other Long-Term Assets
$3.9B
CAGR 3-Years
3%
CAGR 5-Years
9%
CAGR 10-Years
18%
Abbott Laboratories
NYSE:ABT
Other Long-Term Assets
$7.7B
CAGR 3-Years
24%
CAGR 5-Years
27%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Other Long-Term Assets
$1.6B
CAGR 3-Years
21%
CAGR 5-Years
17%
CAGR 10-Years
28%
No Stocks Found

Globus Medical Inc
Glance View

Market Cap
11.5B USD
Industry
Health Care

Globus Medical Inc. is a prominent player in the expanding spinal surgery market, leveraging innovation and patient-centric solutions to elevate the standards of care in orthopedic surgery. Founded in 2003, the company has quickly established itself as a leader by developing a comprehensive range of spinal implants and surgical instruments that emphasize minimally invasive techniques. This focus not only enhances patient recovery but also supports surgeons in their pursuit of optimal outcomes. With a robust pipeline of products and a commitment to research and development, Globus Medical aims to maintain its competitive edge by addressing the evolving needs of healthcare professionals and patients alike. For investors, Globus Medical represents a compelling opportunity, as its strong revenue growth and strategic initiatives indicate a promising future. The company has experienced consistent financial performance, underpinned by a growing market demand for spine-related procedures due to aging demographics and an increase in sports-related injuries. Moreover, Globus has pursued strategic acquisitions and collaborations, which have expanded its product offerings and geographical reach. As healthcare systems increasingly prioritize efficiency and patient outcomes, Globus Medical's innovative approach equips it to thrive in an industry ripe with potential, making it an attractive investment choice for those looking to capitalize on the evolving landscape of medical technology.

GMED Intrinsic Value
86.48 USD
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Globus Medical Inc's Other Long-Term Assets?
Other Long-Term Assets
120.4m USD

Based on the financial report for Sep 30, 2024, Globus Medical Inc's Other Long-Term Assets amounts to 120.4m USD.

What is Globus Medical Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
61%

Over the last year, the Other Long-Term Assets growth was 60%. The average annual Other Long-Term Assets growth rates for Globus Medical Inc have been 48% over the past three years , 41% over the past five years , and 61% over the past ten years .

Back to Top